Actelion close to sealing Ceptaris deal as US approves drug

The US health regulator FDA has approved Ceptaris Therapeutics' topical drug for treatment of a rare form of non-Hodgkin's lymphoma, Actelion said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news